Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Some birth control pills have a higher risk of blood clots than others.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Most women with PCOS have insulin resistance, especially those with phenotype B.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

The document concludes that products like PRP and PRF show promise for tissue healing, but evidence of their effectiveness is inconsistent.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.